Insurance broker NFP's corporate venturing vehicle was among the investors in a round that will accelerate commercialisation of Hound Labs' advanced breathalyser.

US-based cannabis breathalyser developer Hound Labs completed a $30m series D round backed by NFP Ventures, the corporate venturing arm of insurance broker and consultancy NFP, on Tuesday. The round was led by cannabis science and technology-focused private equity fund Intrinsic Capital Partners, with participation from Main Street Advisors, Icon Ventures and Benchmark. Founded in…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.